Ruby Holder - Chief Strategy Officer @ Proteovant Therapeutics

Overview

CB Rank (Person)

Ruby Holder is the Chief Strategy Officer at Proteovant Therapeutics. She attended Duke University.

Number of Current Jobs

is the

Chief Strategy Officer

Hub Name	CB Rank (Hub)
Acquired Pharmaceutical Companies	3,820
Closed Medical Companies	13,219
Closed East Coast Biotechnology Companies	18,408
Closed New York Companies (Top 10K)	5,661
Closed East Coast Pharmaceutical Companies	30,475
Closed United States Pharmaceutical Companies	19,753
Closed Genetics Companies	43,424
Closed Greater New York Area Companies (Top 10K)	5,149
Closed East Coast Medical Companies	19,418
Closed City of New York Companies	8,427

There is no recent news or activity for this profile.